05/05/2025
Campus-based Mosaic TX has shared details of the in-licensing of two clinical-stage oncology programs from Astex Pharmaceuticals.
This agreement transforms Mosaic from a research and platform company to a clinical stage oncology business and supports its mission to bring new therapies to patients who need them most.
Read the full article HERE Mosaic TX